To assist in critical decision making, life sciences companies routinely gather detailed market insights through deep and time-sensitive dialogue with physicians, patients, or payers. Key business questions can vary, but all are critically important: Will this treatment solve an important health problem? How should we design our clinical trial? How should we educate patients and healthcare providers about our therapy? Should we pursue other indications for this therapy or uses for this device?
To participate without travel and in such a flexible way. It is also nice to be able to say something at length, which may be difficult in groups where certain individuals may dominate the discussions.Pulmonologist KOL Participant